JSK Therapeutics, Inc.

SANDY, UT 84092

SBIR Award Summary

Total Number of Awards 4
Total Value of Awards $2.19MM
First Award Date 09/23/10
Most Recent Award Date 09/21/17

Key Personnel

Last Name Name Awards Contact
Johnson Gregory John Johnson 3
Kennedy Thomas Preston Kennedy 3
Shami Paul J Shami 3
NOWOSLAWSKI JOSEPH FELIX NOWOSLAWSKI 1

4 Awards Won

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PAR-14-088
Budget: 09/21/17 - 08/31/18

PROJECT DESCRIPTION ? JSK Therapeutics (JSKT) Direct to Phase II Application Nitric oxide (NO) is a potentially powerful therapy against cancer. Spontaneous NO-generating drugs cannot be used to treat malignancies because of the pleiotropic effects of NO. In particular, NO is a potent vasodilator with resultant hypotension. In order to make NO-b...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-09-113
Budget: 09/17/14 - 01/31/15

DESCRIPTION (provided by applicant): Despite notable achievements over the past two decades, cancer remains a challenging 21st century epidemic demanding new, more effective drugs. Nitric oxide (NO) is well known to kill cancer cells without harming normal bone marrow cells, but until now has not been used directly to treat cancer because of it...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-09-113
Budget: 02/01/12 - 01/31/13

DESCRIPTION (provided by applicant): Despite notable achievements over the past two decades, cancer remains a challenging 21st century epidemic demanding new, more effective drugs. Nitric oxide (NO) is well known to kill cancer cells without harming normal bone marrow cells, but until now has not been used directly to treat cancer because of it...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-09-113
Budget: 09/23/10 - 08/31/11

DESCRIPTION (provided by applicant): Despite notable achievements over the past two decades, cancer remains a challenging 21st century epidemic demanding new, more effective drugs. Nitric oxide (NO) is well known to kill cancer cells without harming normal bone marrow cells, but until now has not been used directly to treat cancer because of it...